Paper20002104
Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist.
Cascio MG and 4 others. Br J Pharmacol, 2010. Cited by 186 papers, by iCite.
Cite this record
ConductScience Library. Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist. Papers, record 20002104. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20002104
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenergic alpha-Agonists | Major topic |
| Cannabinoids | Major topic |
| Serotonin 5-HT1 Receptor Antagonists | Major topic |
| Serotonin Antagonists | Major topic |
| Adrenergic alpha-2 Receptor Agonists | |
| Animals | |
| CHO Cells | |
| Cannabis | |
| Cricetinae | |
| Cricetulus | |
| Dose-Response Relationship, Drug | |
| Humans | |
| Male | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Knockout | |
| Muscle Contraction | |
| Protein Binding | |
| Receptor, Cannabinoid, CB1 | |
| Receptor, Cannabinoid, CB2 | |
| Vas Deferens |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 DA003672 | NIDA NIH HHS | United States | R01DA003672 | PubMed and NIH | NIH RePORTER |
| R37 DA003672 | NIDA NIH HHS | United States | R01DA003672 | PubMed and NIH | NIH RePORTER |
| DA-03672 | NIDA NIH HHS | United States | R01DA003672 | PubMed and NIH | NIH RePORTER |
| R37DA003672 | NIH | NIH RePORTER |
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18354058 | Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8. | J Pharmacol Exp Ther | 2008 | https://conductscience.org/library/papers/18354058 | PubMed |
| 2 | 9336020 | Pharmacology of cannabinoid CB1 and CB2 receptors. | Pharmacol Ther | 1997 | https://conductscience.org/library/papers/9336020 | PubMed |
| 3 | 17245363 | Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. | Br J Pharmacol | 2007 | https://conductscience.org/library/papers/17245363 | PubMed |
| 4 | 10516656 | Structural determinants of the partial agonist-inverse agonist properties of 6'-azidohex-2'-yne-delta8-tetrahydrocannabinol at cannabinoid receptors. | Br J Pharmacol | 1999 | https://conductscience.org/library/papers/10516656 | PubMed |
| 5 | 1658999 | Noradrenaline-ATP co-transmission in the sympathetic nervous system. | Trends Pharmacol Sci | 1991 | https://conductscience.org/library/papers/1658999 | PubMed |
| 6 | 8566121 | A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. | Eur J Pharmacol | 1995 | https://conductscience.org/library/papers/8566121 | PubMed |
| 7 | 15033394 | 6"-Azidohex-2"-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist. | Eur J Pharmacol | 2004 | https://conductscience.org/library/papers/15033394 | PubMed |
| 8 | 4987683 | Chemical basis of hashish activity. | Science | 1970 | https://conductscience.org/library/papers/4987683 | PubMed |
| 9 | 16199061 | Chemical constituents of marijuana: the complex mixture of natural cannabinoids. | Life Sci | 2005 | https://conductscience.org/library/papers/16199061 | PubMed |
| 10 | 11683519 | Stimulation frequency-noradrenaline release relationships examined in alpha2A-, alpha2B- and alpha2C-adrenoceptor-deficient mice. | Naunyn Schmiedebergs Arch Pharmacol | 2001 | https://conductscience.org/library/papers/11683519 | PubMed |
| 11 | 8960884 | Agonist-antagonist characterization of 6'-cyanohex-2'-yne-delta 8-tetrahydrocannabinol in two isolated tissue preparations. | Eur J Pharmacol | 1996 | https://conductscience.org/library/papers/8960884 | PubMed |
| 12 | 4981896 | Psychopharmacological activity of the active constituents of hashish and some related cannabinoids. | Psychopharmacologia | 1969 | https://conductscience.org/library/papers/4981896 | PubMed |
| 13 | 11520889 | Presynaptic autoreceptors in the third decade: focus on alpha2-adrenoceptors. | J Neurochem | 2001 | https://conductscience.org/library/papers/11520889 | PubMed |
| 14 | 17828291 | The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. | Br J Pharmacol | 2008 | https://conductscience.org/library/papers/17828291 | PubMed |
| 15 | 17157480 | Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis. | J Dermatol Sci | 2007 | https://conductscience.org/library/papers/17157480 | PubMed |
| 16 | 18680204 | Alpha2-agonists as analgesic agents. | Med Res Rev | 2009 | https://conductscience.org/library/papers/18680204 | PubMed |
| 17 | 17019247 | Clonidine--a potent analgesic adjuvant. | Curr Opin Anaesthesiol | 2002 | https://conductscience.org/library/papers/17019247 | PubMed |
| 18 | 9374269 | [Gamma-35S]GTP autoradiography allows region-specific detection of muscarinic receptor-dependent G-protein activation in the chick optic tectum. | Brain Res | 1997 | https://conductscience.org/library/papers/9374269 | PubMed |
| 19 | 11698100 | Modulation of transmitter release via presynaptic cannabinoid receptors. | Trends Pharmacol Sci | 2001 | https://conductscience.org/library/papers/11698100 | PubMed |
| 20 | 8666005 | Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens. | Eur J Pharmacol | 1995 | https://conductscience.org/library/papers/8666005 | PubMed |
Cited by129
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 186 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42883319 | Cannabigerol Modulates Blood Pressure and Vascular Reactivity in a Rat Model of Hypertension and Platelet Responses in Human Blood In Vitro. | Molecules | 2026 | https://conductscience.org/library/papers/42883319 | PubMed |
| 42871546 | Cannabigerol Enhances Muscle Strength and Performance in Dexamethasone-Treated Mice. | ACS Pharmacol Transl Sci | 2026 | https://conductscience.org/library/papers/42871546 | PubMed |
| 42829479 | Optimal cannabinoid-terpene combination ratios suppress mutagenicity of gastric reflux in normal and metaplastic esophageal cells. | World J Gastroenterol | 2026 | https://conductscience.org/library/papers/42829479 | PubMed |
| 42793092 | Cannabinoids in Cancer: Molecular Mechanisms of Tumor Cell Death and Translational Opportunities. | Biomolecules | 2026 | https://conductscience.org/library/papers/42793092 | PubMed |
| 42783432 | Cannabigerol at the Interface of the Gut Microbiota and EndoCannabinoidome: Mechanistic Insights into Inflammation and Pain Modulation. | Med Sci (Basel) | 2026 | https://conductscience.org/library/papers/42783432 | PubMed |
| 42744343 | The anterior cingulate cortex mediates cisplatin-induced mechanical allodynia and represents a target for cannabigerol antinociception. | Mol Pain | 2026 | https://conductscience.org/library/papers/42744343 | PubMed |
| 42653723 | Pharmacological Switching in Minor Phytocannabinoids: A Mechanistic Framework for Compound-Indication Matching and Precision Neurotherapeutic Development. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42653723 | PubMed |
| 42394854 | Concomitant activation of D1 dopamine and α2A adrenergic receptors improves cognition better than methylphenidate in two rodent behavioral tests. | Discov Pharm Sci | 2026 | https://conductscience.org/library/papers/42394854 | PubMed |
| 42139799 | Minor cannabinoids CBD, CBG, CBN, and CBC differentially modulate sensory neuron activation. | J Pharmacol Exp Ther | 2026 | https://conductscience.org/library/papers/42139799 | PubMed |
| 42121212 | Cannabidiol and other non-psychotropic cannabinoids from Cannabis sativa as therapeutics for microglial-mediated neuroinflammation and neurodegeneration. | J Cannabis Res | 2026 | https://conductscience.org/library/papers/42121212 | PubMed |
| 41919226 | Elucidating the putative role of cannabigerol: a hypothesis-generating review of neuroinflammatory and neuroprotective mechanisms with implications for drug-resistant epilepsy. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41919226 | PubMed |
| 41794091 | Cannabichromene attenuates fracture pain but impairs bone repair in a murine tibial fracture model. | Bone | 2026 | https://conductscience.org/library/papers/41794091 | PubMed |
| 41646286 | Concomitant activation of D1 dopamine and α2A adrenergic receptors improves cognition compared with methylphenidate. | Res Sq | 2026 | https://conductscience.org/library/papers/41646286 | PubMed |
| 41446792 | Pharmacokinetics and pharmacodynamics of cannabigerol (CBG) in the C57BL/6Crl mouse. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41446792 | PubMed |
| 41423277 | Cannabigerol Exerts In Vivo and In Vitro Anti-Inflammatory Effects via Inhibition of the MAPK and NF-κB Pathways. | J Microbiol Biotechnol | 2025 | https://conductscience.org/library/papers/41423277 | PubMed |
| 41234397 | Metabolism, pharmacokinetics, and bioavailability of cannabigerol in horses following intravenous and oral administration with micellar and oil formulations. | Front Vet Sci | 2025 | https://conductscience.org/library/papers/41234397 | PubMed |
| 41155621 | Cannabigerol Modulates Cannabinoid Receptor Type 2 Expression in the Spinal Dorsal Horn and Attenuates Neuropathic Pain Models. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41155621 | PubMed |
| 41068546 | The Pharmacological Profile of Plant-Derived Cannabinoids In Vitro. | Curr Top Behav Neurosci | 2026 | https://conductscience.org/library/papers/41068546 | PubMed |
| 40917785 | Analgesic and toxicological evaluation of cannabidiol-rich Moroccan Cannabis sativa L. (Khardala variety) extract: Evidence from an in vivo and in silico study. | Open Life Sci | 2025 | https://conductscience.org/library/papers/40917785 | PubMed |
| 40869376 | Cannabigerol Attenuates Memory Impairments, Neurodegeneration, and Neuroinflammation Caused by Transient Global Cerebral Ischemia in Mice. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40869376 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ADRA2B | 151 | PubTator's text mining | https://conductscience.org/library/genes/151 | NCBI Gene |
| CNR1 | 1268 | PubTator's text mining | https://conductscience.org/library/genes/1268 | NCBI Gene |
| HTR1A | 3350 | PubTator's text mining | https://conductscience.org/library/genes/3350 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20002104
GET https://conductscience.org/api/papers/v1/20002104/references?page=2